NIHR Oxford Health Biomedical Research Centre

Improving brain health: the future in mind

You are here: Home / NIHR Oxford Cognitive Health Clinical Research Facility / CRF publications

CRF publications

► 2020 (ongoing)

  • Kappelmann N, Suesse M, Steudte-Schmiedgen S, Kaldewaij R, Browning M, Michael T, Rinck M, Reinecke A. D-Cycloserine as Adjunct to Brief Computerised CBT for Spider Fear: Effects on Fear, Behaviour, and Cognitive Biases. Journal of Behavior Therapy and Experimental Psychiatry, 2020; 68:101546.
  • Heise V, Zsoldos E, Ebmeier KP. Ageing and the human brain. In: Geddes JR, Andreassen N, Goodwin GM. New Oxford Textbook of Psychiatry. 3rd ed. Oxford. Oxford University Press; 2020. p. 170-182.
  • Pollak TA, Lennox BR, Muller S, Benros M…Bechter K. Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. Lancet Psychiatry. 2020; 7(1):93-108
  • Xu N, Huggon B, Saunders KEA. Cognitive Impairment in Patients with Bipolar Disorder: Impact of Pharmacological Treatment. CNS Drugs. 2020 Jan; 34(1):29-46.
  • McGowan N, Goodwin G, Bilderbeck A, Saunders K. Actigraphic patterns, impulsivity and mood instability in bipolar disorder, borderline personality disorder and healthy controls. Acta Psychiatrica Scandanavia. 2020 Jan
  • Kataoka Y, Luo Y, Chaimani A, Onishi A, Kimachi M, Tsujimoto Y, Murad MH, Cipriani A, Furukawa TA. Cumulative network meta-analyses, practice guidelines, and actual prescriptions for postmenopausal osteoporosis: a meta-epidemiological study. 2020 Feb; 15(1): 21
  • Luo Y, Kataoka Y, Ostinelli EG, Cipriani A, Furukawa TA. National Prescription Patterns of Antidepressants in the Treatment of Adults with Major Depression in the US between 1996 and 2015: A Population Representative Survey Based Analysis. Frontiers in Psychiatry. 2020 Feb.
  • Goodday SM, Atkinson L, Goodwin G, Saunders K, South M, Mackay C, Denis M, Hinds C, Attenburrow M-J, Davies J, Welch J, Stevens W, Mansfield K, Suvilehto J, Geddes JR. The True Colours Remote Symptom Monitoring System: A Decade of Evolution. Journal of Medical Internet Research. 2020; 22(1)
  • Cuijpers P, Noma H, Karyotaki E, Vinkers C, Cipriani A, Furukawa T. A network meta‐analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression. World Psychiatry. 2020 Feb; 19(1): 92-107.
  • Incecik E, Taylor RW, Valentini B, Hatch SL, Geddes JR, Cleare AJ, Marwood L. Online mood monitoring in treatment-resistant depression: qualitative study of patient perspectives in the NHS. BJPsych Bulletin 2020
  • Barrera A, Gee C, Wood A, Gibson O, Bayley D, Geddes JR. Introducing artificial intellgience in acute psychiatric inpatient care: qualitative study of its use to conduct nursing observations. Evid Based Mental Health. 2020; 23:34-38.
  • Cipriani A, Ioannidis JPA, Rothwell PM, Li T, Hernandez AF, Tomlinson A, Simes J, Naci H. Generating comparative evidence on new drugs and devices after approval. Lancet. 2020; 395:998-1010
  • Godlewska BR, Harmer CJ. Cognitive neuropsychological theory of antidepressant action: a modern-fay approach to depression and its treatment. Psychopharmacology. 2020
  • Minichino A, Brondino N, Solmi M, Del Giovane C, Fusar-Poli P, Burnet P, Cipriani A, Lennox B. The gut-microbiome as a target for the treatment of schizophrenia: A systematic review and meta-analysis of randomised controlled trials of add-on strategies. Sch Res. 2020. 
  • Koychev I, Vaci N, Bilgel M, An Y, Muniz GT, Wong DF, Gallacher J, Mogekhar A, Albert M, Resnick S. Prediction of rapud amyloid and phospotylated-Tau accomulation in cognitively healthy individuals. Alzheimers Dement. 2020; 12(1): e12019.
  • Szeligowski T, Lim Yu A, Lennox B, Burnet P. The Gut Microbiome and Schizophrenia: The Current State of the Field and Clinical Applications. Front. Psychiatry, 2020. 
  • Vaci N, Liu Q, Kormilitzin A, De Crescenzo F, Kurtulmus A, Harvey J, O’Dell B, Innocent S, Tomlinson A, Cipriani A, Nevado-Holgado A. Natural language processing for structuring clinical text on depression using UK-CRIS. Evidence-Based Mental Health, 2020; 23(1).
  • Singh I, Naci H, Miller J, Caplan A, Cipriani A. Ethical implications of poor comparative effectiveness evidence: obligations in industry-research partnerships. Lancet. 2020; 395(10228):926-928.
  • Browning M. What might prediction tell us about the dopaminergic mechanisms of depression? Biological Psychiatry, 2020; 5(2):163-172.
  • Gross J, Faber NS, Kappes A, Nussberger A-M, Cowen P, Browning M, Kahane G, Savulescu J, Crockett M, De Dreu C. When Helping is Risky: Behavioral and Neurobiological Mechanisms of Prosocial Decisions Entailing Risk. PsyArXiv Preprints, 2020.
  • Sanghani HR, Jagannath A, Humberstone T, Ebrahimjee F, Thomas JM, Churchill GC, Cipriani A, Attenburrow MJ, Perestenko OV, Cowley SA, Zameel Cader A, Peirson SN, Harrison PJ, Foster RG, Goodwin GM, Vasudevan SR. Patient fibroblast circadian rhythms predict lithium sensitivity in bipolar disorder. Molecular Psychiatry, 2020; 10.1038/s41380-020-0769-6.
  • Minichino A, Brondino N, Solmi M, Del Giovane C, Fusar-Poli P, Burnet P, Cipriani A, Lennox BR. The gut-microbiome as a target for the treatment of schizophrenia: A systematic review and meta-analysis of randomised controlled trials of add-on strategies. Schizophrenia Research, 2020; 10.1016/j.schres.2020.02.012.
  • Goodday SM, Kormilitzin A, Vaci N, Liu Q, Cipriani A, Smith T, Nevado-Holgado A. Maximizing the use of social and behavioural information from secondary care mental health electronic health records. Journal of Biomedical informatics, 2020; 107:103429.
  • Luo Y, Chaimani A, Furukawa TA, Kataoka Y, Ogawa Y, Cipriani A, Salanti G. Visualizing the evolution of evidence: Cumulative network meta-analyses of new generation antidepressants in the last 40 years. Research Synthesis Methods, 2020; 1-12.
  • Jack RH, Joseph RM, Coupland C, Butler D, Hollis C, Morriss R, David Knaggs R, Cipriani A, Cortese S, Hippisley-Cox J. Secondary care specialist visits made by children and young people prescribed antidepressants in primary care: a descriptive study using the QResearch database. BMC Medicine, 2020; 18:93.
  • Thompson T, Dias S, Poulter D, Weldon S, Marsh L, Rossato C, Il Shin J, Firth J, Veronese N, Dragioti E, Stubbs B, Solmi M, Maher CG, Cipriani A, Ioannidis JPA. Efficacy and acceptability of pharmacological and non-pharmacological interventions for non-specific chronic low back pain: a protocol for a systematic review and network meta-analysis. Systematic Reviews, 2020; 9:130.
  • De Crescenzo F, Garriga C, Tomlinson A, Coupland C, Efthimiou O, Fazel S, Hippisley-Cox J, Cipriani A. Real-world effect of antidepressants for depressive disorder in primary care: protocol of a population-based cohort study. Evidence Based Mental Health, 2020; 0;1-5.
  • Seo M, Furukawa TA, Angeliki Veroniki A, Pillinger T, Tomlinson A, Salanti G, Cipriani A, Efthimiou O. The Kilim plot: A tool for visualizing network meta-analysis results for multiple outcomes. Research Synthesis Methods, 2020; 1-10.
  • Murphy SE, de Cates AN, Gillespie AL, Godlewska BR, Scaife JC, Wright LC, Cowen PJ, Harmer CJ. Translating the promise of 5HT4 receptor agonists for the treatment of depression. Psychological Medicine, 2020; 1-10.
  • Smith K, Ostinelli E, Cipriani A. COVID-19 and mental health: a transformational opportunity to apply an Evidence-Based approach to clinical practice and research. Evidence Based Mental Health, 2020; 23(2):45-46.
  • Chevance A, Ravaud P, Tomlinson A, Le Berre C, Teufer B, Touboul S, Fried EI, Gartlehner G, Cipriani A, Tran VT. Identifying Outcomes for Depression That Matter to Patients, Informal Caregivers, and Health-care Professionals: Qualitative Content Analysis of a Large International Online Survey. The Lancet Psychiatry, 2020; 7(8):692-702.
  • Cortese S, Solmi M, Arrondo G, Cipriani A, Fusar-Poli P, Larsson H, Correll C. Association between mental disorders and somatic conditions: protocol for an umbrella review. Evid Based Ment Health, 2020; 8:ebmental-2020-300158.
  • Smith K, Bhui K, Cipriani A. COVID-19, mental health and ethnic minorities. Evid Based Ment Health, 2020; 23(3):89-90.
  • Zhou X, Teng T, Zhang Y, Del Giovane C, Furukawa TA, Weisz JR, Li X, Cuijpers P, Coghill D, Xiang Y, Hetrick SE, Leucht S, Qin M, Barth J, Ravindran AV, Yang L, Curry J, Fan L, Silva SG, Cipriani A, Xie P. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis. Lancet Psychiatry, 2020; 7(7):581-601.

► 2019

  • Lennox B, Pollak T, Vincent A. An international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin: the concept of autoimmune. Lancet Psychiatry, 2019; 7(1):93-108.
  • Del Giovane C, Cortese S, Cipriani A. Combining Pharmacological and Nonpharmacological Interventions in Network Meta-analysis in Psychiatry. JAMA Psychiatry. 2019 Apr 17.
  • Lancaster C, Blane J, Chinner A, Wolters L, Koychev I, Hinds C. Evaluating the feasibility of frequent cognitive assessment using the Mezurio smartphone app: Observational and Interview Study in PREVENT dementia cohort members. (Preprint).
  • Walsh A, Matini L, Hinds C, Sexton V, Brain O, Keshav S, Geddes JR, Goodwin G, Collins G, Travis S, Peters M. Real-time data monitoring for ulcerative colitis: patient perception and qualitative analysis. Intestinal research. 2019 Jul;17(3):365-74.
  • Henshall C, Cipriani A, Ruvolo D, Macdonald O, Wolters L, Koychev I. Implementing a digital clinical decision support tool for side effects of antipsychotics: a focus group study. Evidence-based mental health. 2019 May;22(2):56-60.
  • Witt K, Potts J, Hubers A, Grunebaum MF, Murrough JW, Loo C, Cipriani A, Hawton K. Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials. Aust N Z J Psychiatry. 2019 Nov 15.
  • Ward J, Tunbridge EM, Sandor C, Lyall LM, Ferguson A, Strawbridge RJ, Lyall DM, Cullen B, Graham N, Johnston KJA, Webber C, Escott-Price V, Oâ Donovan M, Pell JP, Bailey MES, Harrison PJ, Smith DJ. The genomic basis of mood instability: identification of 46 loci in 363,705 UK Biobank participants, genetic correlation with psychiatric disorders, and association with gene expression and function. 
  • Al-Diwani A, Linighan R, Perkins C, Critchlow G, Lennox BR, Leite MI, Manohar S, Okai D, Irani SR. Journal of Neurology, Neurosurgery and Psychiatry (1468-330X): No; 3.186. p. 90.
  • Faurholt-Jepsen M, Geddes JR, Goodwin GM, Bauer M, Duffy A, Vedel Kessing L, Saunders K. Reporting guidelines on remotely collected electronic mood data in mood disorder (eMOOD)-recommendations.  Transl Psychiatry. 2019 Jun 7;9(1):162.
  • Lennox B, Yeeles K, Jones PB, Zandi M, Joyce E, Yu L-M, Tomei G, Pollard R, Vincent S-A, Shimazaki M, Cairns I, Dowling F, Kabir T, Barnes TRE, Lingford Hughes A, Hosseini AA, Harrower T, Buckley C, Coles A. Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2). Trials. 2019 Jun 7;20(1):331.
  • Huhn M, Nikolakopoulou A, Schneider-Thoma J, Krause M, Samara M, Peter N, Arndt T, Bäckers L, Rothe P, Cipriani A, Davis J, Salanti G, Leucht S. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet (London, England). 2019 Sep; 394 (10202). 939-51. 
  • Leucht S, Chaimani A, Mavridis D, Leucht C, Huhn M, Helfer B, Samara M, Cipriani A, Geddes JR, Davis JM. Disconnection of drug-response and placebo-response in acute-phase antipsychotic drug trials on schizophrenia? Meta-regression analysis. Neuropsychopharmacology. 2019 Oct; 44 (11). 1955-66. 
  • Jones H, Cipriani A. Barriers and incentives to recruitment in mental health clinical trials. Evidence-based mental health. 2019 May;22(2). 49-50.
  • Cipriani A. At what level of severity do we need antidepressive drugs? European Psychiatry (0924-9338): No; 1.819. p. 56.
  • Cipriani A. Network Meta Analysis for Clinical Practice Guidelines. Annals of Internal Medicine.  2019 Aug 27.
  • Freeman D, Yu L-M, Kabir T, Martin J, Craven M, Leal J, Lambe S, Brown S, Morrison A, Chapman K, Dudley R, O’Regan E, Rovira A, Goodsell A, Rosebrock L, Bergin A, Cryer TL, Robotham D, Andleeb H, Geddes JR, Hollis C, Clark DM, Waite F. Automated virtual reality (VR) cognitive therapy for patients with psychosis: study protocol for a single-blind parallel group randomised controlled trial (gameChange). BMJ open. 2019 Aug 27;(8).
  • Furukawa TA, Cowen PJ, Salanti G, Leucht S, Egger M, Cipriani A. Optimal dosing of antidepressant drugs – Authors’ reply. Lancet Psychiatry. 2019 Oct;6(10). 806-07.
  • Lennox Belinda, Minichino A, Godlewska B, Burnet P, Cipriani A. Disturbance of the endocannabinoid system in psychosis  A systematic review and meta-analysis. JAMA Psychiatry. 2019 Jun 5.
  • Tomlinson A, Furukawa TA, Efthimiou O, Salanti G, De Crescenzo F, Singh I, Cipriani A. Personalise antidepressant treatment for unipolar depression combining individual choices, risks and big data (PETRUSHKA): rationale and protocol. Evidence-based mental health. 2019 Oct 23.
  • Cuijpers P, Noma H, Karyotaki E, Cipriani A, Furukawa TA. Effectiveness and Acceptability of Cognitive Behavior Therapy Delivery Formats in Adults With Depression: A Network Meta-analysis. JAMA Psychiatry. 2019 Jul;76(7). 700-07.
  • Duffy A, Saunders KEA, Malhi GS, Patten S, Cipriani A, McNevin SH, MacDonald E, Geddes JR. Mental health care for university students: a way forward? Lancet Psychiatry. 2019 Nov;6(11). 885-87.
  • Lancaster C, Koychev I, Blane J, Chinner A, Wolters L, Hinds C. The Mezurio smartphone application: Evaluating the feasibility of frequent digital cognitive assessment in the PREVENT dementia study. 2019 Sep 4.
  • Walker S, Potts J, Martos L, Barrera A, Hancock M, Bell S, Geddes JR, Cipriani A, Henshall C. Consent to discuss participation in research: a pilot study. Evidence-based mental health. 2019 Sep 26.
  • Tomlinson A, Efthimiou O, Boaden K, New E, Mather S, Salanti G, Imai H, Ogawa Y, Tajika A, Kishimoto S, Kikuchi S, Chevance A, Furukawa TA, Cipriani A. Side effect profile and comparative tolerability of 21 antidepressants in the acute treatment of major depression in adults: protocol for a network meta-analysis. Evidence-based mental health. 2019 May;22(2). 61-66.
  • Harrison PJ, Geddes JR, Tunbridge EM. The Emerging Neurobiology of Bipolar Disorder. Trends in neurosciences. 2018 Jan;41(1). 18-30.
  • Minichino A, Senior M, Brondino N, Zhang SH, Godwlewska BR, Burnet PWJ, Cipriani A, Lennox BR. Measuring Disturbance of the Endocannabinoid System in Psychosis: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2019 Jun 5.
  • Tunbridge EM, Narajos M, Harrison CH, Beresford C, Cipriani A, Harrison PJ. Which Dopamine Polymorphisms Are Functional? Systematic Review and Meta-analysis of COMT, DAT, DBH, DDC, DRD1-5, MAOA, MAOB, TH, VMAT1, and VMAT2. 2019 Oct;86(8). 608-20.
  • Behrman S, Lennox B. Autoimmune encephalitis in the elderly: who to test and what to test for. Biological Psychiatry. 2019 Nov;22(4). 172-76.
  • Jack RH, Hollis C, Coupland C, Morriss R, Knaggs RD, Cipriani A, Cortese S, Hippisley-Cox J. Trends in antidepressant prescriptions in children and young people in England, 1998-2017: protocol of a cohort study using linked primary care and secondary care datasets. Evidence-based mental health. 2019 Aug;22(3). 129-33.
  • Faurholt-Jepsen M, Geddes JR, Goodwin GM, Bauer M, Duffy A, Kessing LV, Saunders KEA. Reporting guidelines on remotely collected electronic mood data in mood disorder (eMOOD) – Recommendations. Evidence-based mental health. 2019 Jun 7.
  • Kernot C, Tomlinson A, Chevance A, Cipriani A. One step closer to personalised prescribing of antidepressants: using real-world data together with patients and clinicians’ preferences. 2019 Aug;22(3). 91-92.
  • Buckley NJ, Tofaris GK. Pathways of Neurodegeneration Underlying Dementia. In: Geddes JR. New Oxford Textbook of Psychiatry.
  • Jauhar S, Hayes J, Goodwin GM, Baldwin DS, Cowen PJ, Nutt DJ. Antidepressants, withdrawal, and addiction; where are we now? Evidence based mental health. J Psychopharmacol. 2019 Jun;33(6). 655-59.
  • Selvaraj S, Jauhar S, Baldwin DS, Cowen PJ, Goodwin G, Hayes JF, Nutt DJ, Veronese M, Young AH. Tapering of SSRI treatment to mitigate withdrawal symptoms. Lancet Psychiatry. 2019 Jul;6(7). 560-61.
  • Geddes JR, Miklowitz DJ, inventors. Treatment of bipolar disorder. United Kingdom patent UK. 2013 May.
  • Tomlinson A, Boaden K, Cipriani A. Withdrawal, dependence and adverse events of antidepressants: lessons from patients and data. Evidence-based mental health. 2019 Nov;22(4). 137-38.
  • Shinohara K, Efthimiou O, Ostinelli EG, Tomlinson A, Geddes JR, Nierenberg AA, Ruhe HG, Furukawa TA, Cipriani A. Comparative efficacy and acceptability of antidepressants in the long-term treatment of major depression: protocol for a systematic review and networkmeta-analysis. BMJ Open. 2019 May 19;9(5).
  • McKnight RF, de La Motte de BroÃns de Vauvert SJGN, Chesney E, Amit BH, Geddes JR, Cipriani A. Lithium for acute mania. The Cochrane database of systematic reviews. 2019 Jun;6.
  • Fazel MS, Rees S, Silove D. Refugees and populations exposed to mass conflict. In: Geddes JR, Andreasen N, Goodwin G. New Oxford Textbook of Psychiatry. 3rd ed. Oxford University Press.
  • Whiting D, Lennox BR, Fazel S. Violent outcomes in first-episode psychosis: A clinical cohort study. Early Interv Psychiatry. 2019 Nov 22.
  • Murphy SE, Wright LC, Browning M, Cowen PJ, Harmer CJ. A role for 5-HT4 receptors in human learning and memory. Psychological medicine. 2019 Oct. 16. 1-9.
  • Lo C, Arora S, Baig F, Lawton MA, El Mouden C, Barber TR, et al. Predicting motor, cognitive & functional impairment in Parkinson’s. Ann Clin Transl Neurol. 2019;6(8):1498-509.
  • Baig F, Kelly MJ, Lawton MA, Ruffmann C, Rolinski M, Klein JC, et al. Impulse control disorders in Parkinson disease and RBD: A longitudinal study of severity. Neurology. 2019;93(7):e675-e87.
  • Kelly MJ, Lawton MA, Baig F, Ruffmann C, Barber TR, Lo C, et al. Predictors of motor complications in early Parkinson’s disease: A prospective cohort study. Mov Disord. 2019;34(8):1174-83.
  • Barber T, Griffanti L, Bradley K, McGowan D, Lo C, Mackay C, Hu M, Klein JC. Nigrosome 1 imaging in REM sleep behaviour disorder and its association with dopaminergic decline.  Ann Clin Transl Neurol. 2019, accepted
  • Ruhe H, Mocking R, Figueroa C, Seeverens P, Ikani N, Browning M, Tyborowska A, Vrijsen J, Harmer C, Schene A. Emotional Biases and Recurrence in Major Depressive Disorder. Results of 2.5 Years Follow-Up of Drug-Free Cohort Vulnerable for Recurrence. Frontiers in psychiatry. 2019 Mar. 
  • Noma H, Furukawa TA, Maruo K, Imai H, Shinohara K, Tanaka S, Ikeda K, Yamawaki S, Cipriani A. Exploratory analyses of effect modifiers in the antidepressant treatment of major depression: Individual-participant data meta-analysis of 2803 participants in seven placebo-controlled randomized trials. J Affect Disord, 2019; 250: 419-424
  • Hiland E, Landro N, Harmer C, Browning M, Maglanoc L, Jonassen R. Attentional bias modification is associated with fMRI Response toward negative stimuli in individuals with residual depression: a randomized controlled trial. J Psychiatry Neurosci 1; 2019.
  • De Cates A, De Cates P, Singh S, Marwaha S. Can curriculum design influence medical students’ attitudes to psychiatry? A comparison of two different approaches. Medical Teacher, 2019; 41 (8), 939-948
  • Sheaves B, Holmes E, Rek S, Taylor K, Nickless A, Waite F, Germain A, Espie C, Harrison P, Foster R, Freeman D. Cognitive Behavioural Therapy for Nightmares for Patients with Persecutory Delusions (Nites): An Assessor-Blind, Pilot Randomized Controlled Trial. Can J Psychiatry, 2019 Oct; 64(10): 686-696
  • Jonassen R, Harmer C, Maglanoc L, Hilland E, Kraft B, Browning M, Stiles T, Haaland V, Berge T, Landro NI. Effects of Attentional Bias Modification on residual symptoms in depression: a randomized controlled trial. BMC Psychiatry 2019, 19. 
  • Pulcu E, Guzman-Holst C, Shkreli L, Woud ML, Browning M, Reinecke A. The Effects of the Angiotensin II Receptor Antagonist Losartan on Appetitive Versus Aversive Learning: A Randomized Controlled Trial. Biological Psychiatry. 2019 Sept; 86(5): 397-404
  • Witt K, Boland A, Lamblin M, McGorry PD, Veness B, Cipriani A, Hawton K, Christensen H, Harvey S, Robinson J. Evid Based Mental Health. Effectiveness of universal programmes for the prevention of suicidal ideation, behaviour and mental ill health in medical students: a systematic review and meta-analysis. Evid Based Mental Health. 2019 Mar
  • Gillett G, Saunders K. Remote Monitoring for Understanding Mechanisms and Prediction in Psychiatry. Curren behavioural neuroscience reports. 2019, 6, 51-56.
  • Furukawa TA, Cipriani A, Cowen P. Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis. The Lancet Psychiatry, 2019; 6(7):601-609
  • McGowan N, Bilderbeck A, Goodwin G, Saunders K. Circadian rest-activity patterns in bipolar disorder and borderline personality disorder. Translational Psychiatry, 2019; 9. 
  • Bhagwagar Z, Goodwin G, Geddes JR. Lithium for acute mania protocol. Cochrane database of systematic reviews. 2019 May
  • Martens M, Antley A, Freeman D, Slater M, Harrison PJ, Tunbridge E. It feels real: physiological responses to a stressful virtual reality environment and its impact on working memory. Journal of psychopharmacology, 2019 Jul.
  • Harrison P, Tunbridge E, Dolphin AC, Hall J. Voltage-gated calcium channel blockers for psychiatric disorders: genomic reappraisal. British Journal of Psychiatry. 2019 
  • Nobis L, Manohar, SG, Smith SM, Alaro-Almagro F, Jenkinson M, Mackay CE, Husain M. Hippocampal volume across age: Nomograms derived from over 19,700 people in UK Biobank. Neuroimage: clinical. 2019; 23.
  • Pulcu E, Browning M. The Misestimation of Uncertainty in Affective Disorders. Trends in cognitive sciences. 2019 Oct; 23(10): 865-875
  • Pillinger T, McCutcheon RA, Vano L, Cipriani A. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. The Lancet Psychiatry 2019; 7(1): 64-77.
  • Jochim J, Rifkin-Zybutz RP, Geddes JR, Cipriani A. Valproate for acute mania. Cochrane database of systematic reviews, 2019; 10.1002/14651858.CD004052.pub2.
  • Harrison P, Hall N, Al-Juffali N, Mould A, Tunbridge E. Cellular calcium in bipolar disorder: systematic review and meta-analysis. Molecular Psychiatry, 2019.
  • Gao L, Yu S, Cipriani A, Wu S, Huang Y, Zhang Z, Yang J, Sun Y, Yang Z, Chai S, Zhang Y, Ji L, Zhan S, Sun F. Neurological Manifestation of Incretin-Based Therapies in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis. Aging and Disease. 2019; 10(6): 1311-1319.
  • Browning M, Carter C, Chatham CHPD, Ouden H d, Gillan C, Baker JT, et al. Realizing the Clinical Potential of Computational Psychiatry: Report from the Banbury Center Meeting, February 2019 
  • Furukawa TA, Salanti G, Cowen PJ, Leucht S, Cipriani A. No benefit from flexible titration above minimum licensed dose in prescribing antidepressants for major depression: systematic review. Acta Psychiatrica Scandanavia. 2019 Dec.
  • Kappelmann N, Suesse M, Steudte-Schmiedgen S, Kaldewaij R, Browning M, Michael T, Rinck M, Reinecke A. D-cycloserine as adjunct to brief computerised CBT for spider fear: Effects on fear, behaviour, and cognitive biases. J Behav Ther Exp Psychiatry. 2019 Dec.
  • Suri S, Topiwala A, Chappell MA, Okell TW, Zsoldos E, Singh-Manoux A, Kivima-ki M, Mackay CE, Ebmeier KP. Association of Midlife Cardiovascular Risk Profiles With Cerebral Perfusion at Older Ages. JAMA Network Open. 2019; 2(6):e195776.
  • Browning M, Den Ouden H, Gillan C, Baker J, Cools R, Gold J, Goldstein R, Hartley C, Lawson R, Pizzagalli D, Powers A, Rindskopf D, Roiser J, Huys Q, Paulus M, Carter C, Chatham C, Chekroud A, Dayan P, Kepecs A, Mourao-Miranda J, Philips M, Schmack K, Schiller D, Sebold M. Realizing the Clinical Potential of Computational Psychiatry: Report from the Banbury Center Meeting, February 2019.

Cookies

This site uses cookies: See our privacy policy